Close Menu

Assessing Affy’s Affairs

Premium

By Jennifer Friedlin

 

Affymetrix is undoubtedly the market leader in the micro- array field, having created and built an entire sector around the idea of putting DNA on chips. But a recent spate of bad news from Affymetrix and indications that a slew of companies are gearing up to launch competitive products begs the question of whether Affy’s position is as secure as it is legendary.

Get the full story with
GenomeWeb Premium

Only $95 for the
first 90 days*

GenomeWeb Premium gives you:
✔ Full site access
✔ Interest-based email alerts
✔ Access to archives

Never miss another important industry story.

Try GenomeWeb Premium now.

You may already have institutional access!

Check if I qualify.

Already a GenomeWeb or 360Dx Premium member?
Login Now.

*Before your trial expires, we’ll put together a custom quote with your long-term premium options.

Not ready for premium?

Register for Free Content
You can still register for access to our free content.

Politico reports that the NYPD DNA database has grown since it announced it would be removing profiles from it.

Forbes reports that a structural biology lab at Oxford University studying the coronavirus was hacked.

Science reports that a Dutch research funding agency is combating a ransomware attack.

In Science this week: set of 64 haplotype assemblies from 32 individuals, and more.